Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pulmonology
Volume 2011, Article ID 485952, 3 pages
http://dx.doi.org/10.1155/2011/485952
Case Report

First Report of a Case of Pneumococcal Meningitis Which Did Not Respond to the Ceftriaxone Therapy despite the Isolated Organism Being Sensitive to This Antibiotic In Vitro

1Department of infectious disease, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
2Microbiology and Virology Research Center, Ghaem University Hospital and Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 9188974645, Iran

Received 23 June 2011; Accepted 24 August 2011

Academic Editors: F. L. Fimognari and K. Watanabe

Copyright © 2011 Maryam Mojtabavi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. R. Stein, D. J. Weber, and M. Kelley, “Using hospital antibiogram data to assess regional pneumococcal resistance to antibiotics,” Emerging Infectious Diseases, vol. 9, no. 2, pp. 211–216, 2003. View at Google Scholar · View at Scopus
  2. Centers for Disease Control and Prevention, “Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of a working group,” Morbidity and Mortality Weekly Report, vol. 45, pp. 1–21, 1996. View at Google Scholar
  3. M. Auburtin, R. Porcher, F. Bruneel et al., “Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 cases,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 5, pp. 713–717, 2002. View at Google Scholar · View at Scopus
  4. M. L. Durand, S. B. Calderwood, D. J. Weber et al., “Acute bacterial meningitis in adults—A review of 493 episodes,” New England Journal of Medicine, vol. 328, no. 1, pp. 21–28, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. Centers for Disease Control and Prevention, Active Bacterial Core Surveillance (ABCs) Report. Emerging Infectious Program Network. Streptococcus Pneumoniae (preliminary), The Centers, Atlenta, Ga, USA, 2000.
  6. G. V. Doern, A. B. Brueggemann, H. Huynh, E. Wingert, and P. Rhomberg, “Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98,” Emerging Infectious Diseases, vol. 5, no. 6, pp. 757–765, 1999. View at Google Scholar · View at Scopus
  7. G. V. Doern, K. P. Heilmann, H. K. Huynh, P. R. Rhomberg, S. L. Coffman, and A. B. Brueggemann, “Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 6, pp. 1721–1729, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. D. F. Sahm, J. A. Karlowsky, L. J. Kelly et al., “Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 4, pp. 1037–1042, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. C. Thornsberry, D. F. Sahm, L. J. Kelly et al., “Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST surveillance program, 1999-2000,” Clinical Infectious Diseases, vol. 34, supplement 1, pp. S4–S16, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. M. E. Falagas, I. I. Siempos, I. A. Bliziotis, and G. Z. Panos, “Impact of initial discordant treatment with β-lactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: a systematic review,” Mayo Clinic Proceedings, vol. 81, no. 12, pp. 1567–1574, 2006. View at Google Scholar · View at Scopus
  11. J. F. Moroney, A. E. Fiore, L. H. Harrison et al., “Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance,” Clinical Infectious Diseases, vol. 33, no. 6, pp. 797–805, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. S. L. Kaplan and E. O. Mason Jr., “Management of infections due to antibiotic-resistant Streptococcus pneumoniae,” Clinical Microbiology Reviews, vol. 11, no. 4, pp. 628–644, 1998. View at Google Scholar · View at Scopus
  13. V. J. Quagliarello and W. M. Scheld, “Treatment of bacterial meningitis,” New England Journal of Medicine, vol. 336, no. 10, pp. 708–716, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. M. M. Sloas, F. F. Barrett, P. J. Chesney et al., “Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis,” Pediatric Infectious Disease Journal, vol. 11, no. 8, pp. 662–666, 1992. View at Google Scholar · View at Scopus
  15. P. F. Viladrich, F. Gudiol, J. Linares et al., “Evaluation of vancomycin for therapy of adult pneumococcal meningitis,” Antimicrobial Agents and Chemotherapy, vol. 35, no. 12, pp. 2467–2472, 1991. View at Google Scholar · View at Scopus
  16. National Committee for Clinical Laboratory Standards, Performance Standards for Antimicrobial Susceptibility Testing, Twelfth informational supplement, NCCLS, Wayne, Pa, USA, 2002, publication no. M100-S12.
  17. K. P. Klugman, “Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections,” European Respiratory Journal, vol. 20, no. 36, pp. 3s–8s, 2002. View at Google Scholar · View at Scopus
  18. S. C. Buckingham, S. P. Brown, and V. H. San Joaquin, “Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia,” Journal of Pediatrics, vol. 132, no. 1, pp. 174–176, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. S. F. Dowell, T. Smith, K. Leversedge, and J. Snitzer, “Failure of treatment of pneumonia associated with highly resistant pneumococci in a child,” Clinical Infectious Diseases, vol. 29, no. 2, pp. 462–463, 1999. View at Google Scholar · View at Scopus
  20. R. S. Daum, J. P. Nachman, C. D. Leitch, and F. C. Tenover, “Nosocomial epiglottitis associated with penicillin- and cephalosporin- resistant Streptococcus pneumoniae bacteremia,” Journal of Clinical Microbiology, vol. 32, no. 1, pp. 246–248, 1994. View at Google Scholar · View at Scopus
  21. P. J. Chesney, Y. Davis, B. K. English, and W. C. Wang, “Occurrence of Streptococcus pneumoniae meningitis during vancomycin and cefotaxime therapy of septicemia in a patient with sickle cell disease,” Pediatric Infectious Disease Journal, vol. 14, no. 11, pp. 1013–1015, 1995. View at Google Scholar · View at Scopus
  22. C. C. John, “Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review,” Clinical Infectious Diseases, vol. 18, no. 2, pp. 188–193, 1994. View at Google Scholar · View at Scopus
  23. M. J. Catalán, J. M. Fernández, A. Vazquez, E. V. De Seijas, A. Suárez, and J. C.L. De Bernaldo Quirós, “Failure of cefotaxime in the treatment of meningitis due to relatively resistant streptococcus pneumoniae,” Clinical Infectious Diseases, vol. 18, no. 5, pp. 766–769, 1994. View at Google Scholar
  24. S. W. Kim, J. H. Jin, S. J. Kang et al., “Therapeutic efficacy of meropenem for treatment of experimental penicillin-resistant pneumococcal meningitis,” Journal of Korean Medical Science, vol. 19, no. 1, pp. 21–26, 2004. View at Google Scholar · View at Scopus
  25. C. P. Doit, S. P. Bonacorsi, A. J. Fremaux et al., “In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis,” Antimicrobial Agents and Chemotherapy, vol. 38, no. 11, pp. 2655–2659, 1994. View at Google Scholar